Streamline Health Solutions (NASDAQ:STRM – Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.04) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.02, MarketWatch Earnings reports. The business had revenue of $5.77 million during the quarter. Streamline Health Solutions had a negative net margin of 44.61% and a negative return on equity of 31.35%.
Streamline Health Solutions Price Performance
STRM opened at $0.78 on Friday. The company has a fifty day moving average price of $1.21 and a two-hundred day moving average price of $1.49. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.80 and a current ratio of 0.80. Streamline Health Solutions has a 52 week low of $0.75 and a 52 week high of $2.35. The firm has a market capitalization of $45.95 million, a PE ratio of -3.90 and a beta of 1.27.
Wall Street Analyst Weigh In
Separately, StockNews.com began coverage on shares of Streamline Health Solutions in a report on Wednesday. They set a “sell” rating for the company.
Hedge Funds Weigh In On Streamline Health Solutions
A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. boosted its position in shares of Streamline Health Solutions by 4.2% during the third quarter. Vanguard Group Inc. now owns 1,564,842 shares of the company’s stock worth $1,862,000 after purchasing an additional 63,679 shares in the last quarter. BlackRock Inc. boosted its position in shares of Streamline Health Solutions by 3.2% during the first quarter. BlackRock Inc. now owns 426,079 shares of the company’s stock worth $767,000 after purchasing an additional 13,297 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Streamline Health Solutions by 8.7% during the second quarter. Geode Capital Management LLC now owns 396,423 shares of the company’s stock worth $503,000 after purchasing an additional 31,861 shares in the last quarter. UBS Group AG bought a new position in shares of Streamline Health Solutions during the first quarter worth $610,000. Finally, Renaissance Technologies LLC boosted its position in shares of Streamline Health Solutions by 7.1% during the second quarter. Renaissance Technologies LLC now owns 301,869 shares of the company’s stock worth $383,000 after purchasing an additional 20,100 shares in the last quarter. 34.60% of the stock is owned by institutional investors.
About Streamline Health Solutions
Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.
- Five stocks we like better than Streamline Health Solutions
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- 5 Reasons Apple’s New Phone Moves the Needle: 5 That It Won’t
- How to Calculate Stock Profit
- MarketBeat Week in Review – 9/11 – 9/15
- Airline Stocks – Top Airline Stocks to Buy Now
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
Receive News & Ratings for Streamline Health Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions and related companies with MarketBeat.com's FREE daily email newsletter.